Breadcrumb

Robert J. Kreitman, M.D.

Robert J. Kreitman, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Laboratory of Molecular Biology

RESEARCH SUMMARY

Dr. Kreitman has been working in the immunotoxin field since 1989, and has been directing clinical trials with immunotoxins since 1996. He also specializes in the treatment of hairy cell leukemia with immunotoxins and other agents.

Areas of Expertise

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them. 

Publications

Selected Recent Publications

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang HW, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James L, Wilson W, Braylan RC, Calvo KR, Maric I, Dulau-Florea A, Kreitman RJ.
J. Clin. Oncol. JCO1902250, 2020. [ Journal Article ]

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, Maloisel F, Ravandi F, Rousselot P, Rummel M, Siddiqi T, Tadmor T, Troussard X, Yi CA, Saglio G, Roboz GJ, Balic K, Standifer N, He P, Marshall S, Wilson W, Pastan I, Yao NS, Giles F.
Leukemia. 32(8): 1768-77, 2018. [ Journal Article ]

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up

Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, FitzGerald DJ, Santiago L, Gao G, Lanasa MC, Pastan I.
Blood. 131(21): 2331-34, 2018. [ Journal Article ]

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Wayne AS, Shah NN, Bhojwani D, Silverman LB, Whitlock JA, Stetler-Stevenson M, Sun W, Liang M, Yang J, Kreitman RJ, Lanasa MC, Pastan I.
Blood. 130(14): 1620-27, 2017. [ Journal Article ]

Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins

Antignani A, Segal D, Simon N, Kreitman RJ, Huang D, FitzGerald DJ.
Oncogene. 36(35): 4953-62, 2017. [ Journal Article ]

Job Vacancies

We have no open positions in our group at this time, please check back later.

To see all available positions at CCR, take a look at our Careers page. You can also subscribe to receive CCR's latest job and training opportunities in your inbox.

Team

Program Assistant
Barbara Debrah
Patient Care Coordinator
Sonya C. Duke
Research Nurse
Julia Feurtado, RN
Nurse Practitioner
Lacey James-Echenique, CRNP
Postbaccalaureate Fellow (CRTA)
Nathan Ruchelman
Research Nurse
Theresa Yu, RN
Research Biologist
Hong Zhou